期刊文献+

南瓜蛋白联合常用化疗药物对人胰腺癌BxPC-3细胞的体外抑制作用

Cucurmosin combined with common chemotherapeutic drugs inhibited human pancreatic cancer cell line BxPC-3 in vitro
原文传递
导出
摘要 目的研究南瓜蛋白(CUS)联合胰腺癌常用化疗药物吉西他滨(GEM)、氟尿嘧啶(5-FU)、紫杉醇(erx)、顺铂(DDP)对人胰腺癌细胞株BxPC-3的增殖抑制作用。方法采用磺酰罗丹明B(SRB)比色法测定CUS分别与GEM、5-FU、PTX、DDP联用对体外培养的BxPC-3细胞的增殖抑制作用;应用集落形成实验测定CUS分别与GEM、5-FU、PTX、DDP联用对体外培养的BxPC-3细胞集落形成的影响;用金氏公式判断药物联用的协同效果。结果CUS联用GEM、5-FU、HIX、DDP对BxPC.3细胞的增殖抑制率均大于各药单用的抑制率,q〉0.85;CUS与胰腺癌常用化疗药物均在低浓度范围内联用的相加效果明显。CUS联用GEM、5-FU、PTX、DDP对BxPC-3细胞的集落形成抑制率均大于各药单用的抑制率,q〉1.15。结论CUS联合GEM、5-FU、PTX、DDP常用化疗药物对体外培养的BxPC-3细胞的生长抑制具有较好的协同作用。 Objective To investigate the inhibitory effect of cucurmosin (CUS) combined with the commonly used chemotherapeutic drugs for pancreatic cancer in clinical practice including Gemcitabine (GEM) , Fluorouracil (5-FU) , Paclitaxel (PTX) and Cisplatin (DDP) on cell proliferation of human pan- creatic cancer cell line BxPC-3. nehtods Sulforhodamine B (SRB) assay was used to detect the inhibition on the cell proliferation of BxPC-3 cells in vitro after the treatment of CUS combined with GEM, 5-FU, PTX and DDP, respectively. Colony formation assay was also conducted and Jin' s formula was used to assess the synergistic effect of these combinations. Results The inhibition rate of CUS combined with GEM, 5-FU, PTX and DDP were all higher than those of each drug alone ( q 〉 0.85 ) , which became obvious in low con- centrations. The colony formation inhibition rate of CUS combined with GEM, 5-FU, PTX or DDP were all higher than each single drug treatment (q 〉 1.15). Conclusion CUS could enhance the cell growth inhibi- tion of GEM, 5-FU. PTX and DDP in BxPC-3 cells in vitro with a good svnergistic effect.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2015年第9期629-632,共4页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金(30772587) 福建医科大学重大科研项目(09ZD012) 福建省自然科学基金(C0510012,2011J01188)
关键词 南瓜蛋白 胰腺癌 化疗药物 细胞增殖 协同作用 Cucurmosin Pancreatic cancer Chemotherapeutic drugs Cell Proliferation Synergistic effect
  • 相关文献

参考文献13

  • 1蔡龙,王明,郑晓风,暨玲,蔡华杰,阮小蛟.胰腺癌171例临床诊治分析[J].中华肝胆外科杂志,2013,19(7):550-551. 被引量:11
  • 2高崇崇,刘殿刚,曹峰,李非.胰腺癌上调因子在胰腺癌发生、发展中的作用机制[J].中华肝胆外科杂志,2014,20(4):317-320. 被引量:7
  • 3Maiti S, Park N, Han JH, et al. Gemcitabine-coumarin-biotin conjugates : a target specific theranostic anticancer prodrug[ J ]. J Am Chem Soe, 2013,135 ( 11 ) :4567-4572.
  • 4Tamburrino A, Piro G, Carbone C, et al. Mechanisms of resis- tance to chemotherapeutic and anti-angiogenic drugs as novel tar- gets for pancreatic cancer therapy [ J ]. Frontiers Pharmacol,2013,4(4) :56.
  • 5Hou XM, Meehan E J, Xie JM, et al. Atomic resolution structure of cueurmosin, a novel type 1 ribosome-inactivating protein from the sarcocarp of Cueurbita mosehata[ J]. J Struet Biol, 2008,164 (1) :81-87.
  • 6张宝明,黄鹤光,谢捷明,陈明晃,王丛菲,殷强,杨爱琴.南瓜蛋白经表皮生长因子受体信号通路诱导人胰腺癌细胞SW1990凋亡[J].中华肝胆外科杂志,2012,18(9):700-703. 被引量:1
  • 7Wang CF, Yang AQ, Zhang BM, et al. PANC-1 Pancreatic can- cer cell growth inhibited by Cucurmosin alone and in combination with an epidermal growth factor receptor-targeted drug [ J ]. Pancreas, 2014,43 (2) :291-297.
  • 8Xie JM, Wang CF, Yang AQ, et al. Cucurmosin kills human pan- creatic cancer SW-1990 Cells in vitro and in vivo[ J]. Anti Cancer Agents Med Chem, 2013,13 (6) :952-956.
  • 9Ng YM, Yang Y, Sze KH, et al. Structural characterization and anti-HIV-1 activities of arginine/glutamate-rich polypeptide Luffin P1 from the seeds of sponge gourd (Luffa cylindfica) [ J]. J Struct Biol, 2011,174( 1 ) :164-172.
  • 10许春森,黄鹤光,陈明晃,谢捷明.南瓜蛋白诱导胰腺癌细胞对吉西他滨的化疗增敏作用[J].中华实验外科杂志,2012,29(8):1623-1623. 被引量:1

二级参考文献55

  • 1周国中,李兆申.胰腺癌1027例临床流行病学研究[J].世界华人消化杂志,2005,13(1):55-60. 被引量:6
  • 2Hou XM, Meehan E J, Xie JM, et al. Atomic resolution structure of cucurmosin, a novel type 1 ribosome-inactivating protein from the sarcocarp of Cucurbita moschata. J Struct Biol,2008,164:81-87.
  • 3Muller MW, Friess H, Koninger J, et al. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas[J]. Am J Surg, 2008, 195:221-228.
  • 4Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface [J]. Aliment Pharmacol Ther, 2006,24:87-94.
  • 5Makrilia N,Syrigos KN,Saif MW,et al. Treatment for refractory pancreatic cancer[J]. J Pancreas, 2011, 12 : 110-113.
  • 6Bayraktar S,Rocha-Lima MC. Advanced or metastatic pancreatic cancer molecular targeted therapies[J]. Mt Sinai J Med, 2010,77:606-619.
  • 7Hou XM, Meehan EJ, Xie JM, et al. Atomic resolution structure of eucurmosin, a noveltype I ribosome inactivating protein from the sarcocarp of cucurbita moschata[J]. J Structural Bio, 2008,164:81-87.
  • 8Failer BA, Burtness B. Treatment of pancreatic cancer with epidermal growth factor receptor targeted therapy[J]. Biologics, 2009,3:419-428.
  • 9Zhang Y, Banerjee S, Wang Z, et al. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factovkappa B in pancreatic caneer[J]. Cancer Res, 2006,66 : 1025-1032.
  • 10Pino MS, Shrader M, Baker CH, et al. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (lressa) in human pancreatic cancer cell lines[J]. Cancer Res, 2006,66 : 3802-3812.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部